Skip to content
Thursday 8 September

Slides / Recording

Since oral PrEP was first approved for use in 2012, dozens of countries have approved the product and use is expanding. But the pace of scale-up has been slower than expected and PrEP remains out of reach for many who may benefit from it. In this webinar, scientists, policymakers, and funders will tackle difficult questions such as: What will it take to effectively scale up access to existing and emerging PrEP products? What is preventing PrEP scale-up from happening now? And, what is required to transition from PrEP demonstration projects and early introduction efforts to integration within a comprehensive national HIV prevention response? The session will also explore how new guidance from the World Health Organization on simplified and differentiated delivery of PrEP can facilitate more widespread uptake of PrEP.